{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Rockford",
      "address_1": "4901 Hiawatha Dr",
      "reason_for_recall": "Presence of Particulate Matter",
      "address_2": "",
      "product_quantity": "2,455 vials",
      "code_info": "Lot #: 7801221, 7801222, Exp 03/16",
      "center_classification_date": "20150814",
      "distribution_pattern": "Nationwide and Puerto Rico",
      "state": "IL",
      "product_description": "Gemcitabine for Injection, USP, 2 g*/vial, Lyophilized powder in a Single-Use Vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL  61103, Made in India, NDC 67457-463-02, UPC 3 67457 46302 5.",
      "report_date": "20150826",
      "classification": "Class I",
      "openfda": {},
      "recalling_firm": "Mylan Institutional LLC",
      "recall_number": "D-1333-2015",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "71004",
      "termination_date": "20160520",
      "more_code_info": "",
      "recall_initiation_date": "20150323",
      "postal_code": "61103-1287",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}